October 31, 2014: It’s Halloween at last! In the final installment of BioSpace’s spooky-themed features, we decided to go right to the top—to the C-level suite, in fact. This is our look at some of the biotech companies that said “Off with their heads!” to their executives this year...
October 31, 2014: Impax Laboratories, Inc. said today that it will launch a new phase of reorganization in its generic research and development departments in order to re-strategize its priorities after axing 49 jobs recently.
October 31, 2014: Swiss biopharma Novartis said this week it will be leasing a 80,000 square foot building in King of Prussia, Pa., which may be part of its recently announced partnership with the University of Pennsylvania to research cell therapies.
October 31, 2014: Ireland-based Perrigo Co. is in exclusive talks to buy Belgian-based Omega Pharma, beating out suitors including Sanofi, Actavis and Boehringer Ingelheim, reported Bloomberg Friday.